US genetic testing panels schedules meeting:
This article was originally published in Clinica
The US Health and Human Service Secretary's Advisory Committee on Genetic Testing (SACGT) will meet on October 25-26 to finalise its plans for gathering public perspectives on how genetic testing should be regulated. The meeting will be held in Bethesda, Maryland. Individuals who wish to provide public comments should notify Sara Carr, SACGT executive secretary (tel: +1 301 496 9838 or email: email@example.com) and submit their remarks by October 15.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.